These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 6149993)
21. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Jones EA; Schafer DF; Ferenci P; Pappas SC Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394 [TBL] [Abstract][Full Text] [Related]
22. The gamma-aminobutyric acid (GABA) system and hepatic encephalopathy. Roberts E Hepatology; 1984; 4(2):342-5. PubMed ID: 6706307 [No Abstract] [Full Text] [Related]
23. [Nosography and pathophysiology of hepatic encephalopathy]. Fiaccadori F Ann Ital Med Int; 1986 Sep; 1(3):255-65. PubMed ID: 3079370 [No Abstract] [Full Text] [Related]
24. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210 [TBL] [Abstract][Full Text] [Related]
25. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368 [TBL] [Abstract][Full Text] [Related]
26. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865 [TBL] [Abstract][Full Text] [Related]
27. Theories of the pathogenesis of hepatic encephalopathy. Jones EA; Mullen KD Clin Liver Dis; 2012 Feb; 16(1):7-26. PubMed ID: 22321462 [TBL] [Abstract][Full Text] [Related]
28. Portal-systemic encephalopathy and hepatic coma. Jensen DM Med Clin North Am; 1986 Sep; 70(5):1081-92. PubMed ID: 2874273 [TBL] [Abstract][Full Text] [Related]
29. The GABA hypothesis--state of the art. Jones EA; Yurdaydin C; Basile AS Adv Exp Med Biol; 1994; 368():89-101. PubMed ID: 7741019 [No Abstract] [Full Text] [Related]
32. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies. Jones EA; Yurdaydin C; Basile AS Alcohol Alcohol Suppl; 1993; 2():175-80. PubMed ID: 7748296 [TBL] [Abstract][Full Text] [Related]
33. Hepatic encephalopathy and the neural regulation of hypothalamic pituitary function. Van Thiel DH; Gavaler JS; Tarter R; Schade RR; Stone BG Semin Liver Dis; 1985 Feb; 5(1):70-83. PubMed ID: 2858919 [No Abstract] [Full Text] [Related]
34. Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Baraldi M; Zeneroli ZL Science; 1982 Apr; 216(4544):427-9. PubMed ID: 6280279 [TBL] [Abstract][Full Text] [Related]
35. Benzodiazepine-receptor antagonists and hepatic encephalopathy: where do we stand? Mullen KD; Basile AS Gastroenterology; 1993 Sep; 105(3):937-40. PubMed ID: 8395446 [No Abstract] [Full Text] [Related]
36. Current concepts in the pathophysiology of hepatic encephalopathy. Ferenci P; Püspök A; Steindl P Eur J Clin Invest; 1992 Sep; 22(9):573-81. PubMed ID: 1360897 [No Abstract] [Full Text] [Related]
37. Pathogenesis and treatment of portal-systemic encephalopathy: an update. Butterworth RF Dig Dis Sci; 1992 Mar; 37(3):321-7. PubMed ID: 1346515 [No Abstract] [Full Text] [Related]